156 related articles for article (PubMed ID: 4910168)
1. The evaluation of present antileprosy compounds.
Browne SG
Adv Pharmacol Chemother; 1969; 7():211-51. PubMed ID: 4910168
[No Abstract] [Full Text] [Related]
2. The evaluation of present antileprosy compounds.
Browne SG
Adv Pharmacol (1962); 1969; 7():211-51. PubMed ID: 4190238
[No Abstract] [Full Text] [Related]
3. WHO expert committee on leprosy.
World Health Organ Tech Rep Ser; 1970; 459():3-31. PubMed ID: 4993944
[No Abstract] [Full Text] [Related]
4. A new analogous model for the detection and evaluation of chemotherapeutic products effective in leprosy.
Freerksen E; Rosenfeld M
Arzneimittelforschung; 1972 Aug; 22(8):1235-42. PubMed ID: 4678384
[No Abstract] [Full Text] [Related]
5. Antileprosy drugs.
Br Med J; 1971 Jul; 3(5767):174-6. PubMed ID: 4104273
[No Abstract] [Full Text] [Related]
6. Studies on sulfone resistance in leprosy. 3. A case of "partial" resistance.
Pearson JM; Pettit JH; Rees RJ
Int J Lepr Other Mycobact Dis; 1968; 36(2):171-8. PubMed ID: 4877115
[No Abstract] [Full Text] [Related]
7. Chemotherapy of leprosy.
Leiker DL
Int J Lepr Other Mycobact Dis; 1971; 39(2):462-6. PubMed ID: 4948084
[No Abstract] [Full Text] [Related]
8. The treatment of leprosy and its acute complications.
Jopling WH
Trop Doct; 1973 Jan; 3(1):8-11. PubMed ID: 4120944
[No Abstract] [Full Text] [Related]
9. Treatment of leprosy with Lampren (B.663 Geigy).
De las Aguas JT
Int J Lepr Other Mycobact Dis; 1971; 39(2):493-503. PubMed ID: 4948089
[No Abstract] [Full Text] [Related]
10. Therapy of leprosy.
Convit J; Browne SG; Languillon J; Pettit JH; Ramanujam K; Sagher F; Sheskin J; Tarabini G; de Souza Lima L; Tolentino JG; Waters MF; Bechelli LM; Martínez Domínguez V
Bull World Health Organ; 1970; 42(5):667-72. PubMed ID: 5311056
[TBL] [Abstract][Full Text] [Related]
11. Armadillos (Dasypus novemcinctus) as a model to test antileprosy vaccines; a preliminary report.
Job CK; Sanchez RM; Hunt R; Truman RW; Hastings RC
Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):394-7. PubMed ID: 8228437
[TBL] [Abstract][Full Text] [Related]
12. Leprosy--a complementary contribution.
Trop Doct; 1973 Jul; 3(3):97-8. PubMed ID: 4736659
[No Abstract] [Full Text] [Related]
13. [Comparative study of the activity of 6 antileprosy drugs].
Languillon J
Med Trop (Mars); 1969; 29(6):694-8. PubMed ID: 4927959
[No Abstract] [Full Text] [Related]
14. Clofazimine (B663, Geigy) in leprosy reactions.
Smith RB
Australas J Dermatol; 1972 Apr; 13(1):31-5. PubMed ID: 5082494
[No Abstract] [Full Text] [Related]
15. [In vitro immunologic changes in 6 lepromatous leprosy or borderline leprosy patients treated with BCG alone or BCG and lepromin for 12 to 20 months, followed by BCG and antibiochemotherapy for 1 to 2 years].
Saint-André P; Ferracci C; Baquillon G; Travi Piacentile M
Acta Leprol; 1979; (76-77):311-4. PubMed ID: 121851
[No Abstract] [Full Text] [Related]
16. [On the chemoresistance of the Hansen bacillus and the treatment of leprosy with drug associations].
Floch HA
Bull Soc Pathol Exot Filiales; 1966; 59(2):188-92. PubMed ID: 6012833
[No Abstract] [Full Text] [Related]
17. Chemotherapeutic trials in leprosy. 3. Pilot trial of a riminophenazine derivative. B.663, in the treatment of lepromatous leprosy.
Pettit JH; Rees RJ; Ridley DS
Int J Lepr Other Mycobact Dis; 1967; 35(1):25-33. PubMed ID: 5336368
[No Abstract] [Full Text] [Related]
18. [. 663 (G 30320 "Geigy"), a new chemotherapeutic agent against leprosy].
Vischer WA
Schweiz Med Wochenschr; 1967 Mar; 97(10):308. PubMed ID: 5585384
[No Abstract] [Full Text] [Related]
19. BCG vaccination in leprosy.
Price JE
Int J Lepr Other Mycobact Dis; 1982 Jun; 50(2):205-12. PubMed ID: 6749707
[No Abstract] [Full Text] [Related]
20. Leprosy research at the National Institutes of Health: experience with B.663 in the treatment of leprosy.
Williams TW; Mott PD; Wertlake PT; Rubio JB; Adler RC; Hill GJ; Suarez GP; Knight V
Int J Lepr; 1965; 33(3):Suppl:767-77. PubMed ID: 5322715
[No Abstract] [Full Text] [Related]
[Next] [New Search]
